Literature DB >> 10725406

BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10alpha in activated transcription.

B P Schlegel1, V J Green, J A Ladias, J D Parvin.   

Abstract

The functions of most of the 12 subunits of the RNA polymerase II (Pol II) enzyme are unknown. In this study, we demonstrate that two of the subunits, hRPB2 and hRPB10alpha, mediate the regulated stimulation of transcription. We find that the transcriptional coactivator BRCA1 interacts directly with the core Pol II complex in vitro. We tested whether single subunits from Pol II would compete with the intact Pol II complex to inhibit transcription stimulated by BRCA1. Excess purified Pol II subunits hRPB2 or hRPB10alpha blocked BRCA1- and VP16-dependent transcriptional activation in vitro with minimal effect on basal transcription. No other Pol II subunits tested inhibited activated transcription in these assays. Furthermore, hRPB10alpha, but not hRPB2, blocked Sp1-dependent activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725406      PMCID: PMC16207          DOI: 10.1073/pnas.97.7.3148

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Mutations in the three largest subunits of yeast RNA polymerase II that affect enzyme assembly.

Authors:  P A Kolodziej; R A Young
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

2.  Activation of class II gene transcription by regulatory factors is potentiated by a novel activity.

Authors:  M Meisterernst; A L Roy; H M Lieu; R G Roeder
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

Review 3.  RNA polymerase II.

Authors:  R A Young
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

4.  BRCA1 physically associates with p53 and stimulates its transcriptional activity.

Authors:  H Zhang; K Somasundaram; Y Peng; H Tian; H Zhang; D Bi; B L Weber; W S El-Deiry
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

5.  Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography. Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody.

Authors:  N E Thompson; D B Aronson; R R Burgess
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

6.  Five intermediate complexes in transcription initiation by RNA polymerase II.

Authors:  S Buratowski; S Hahn; L Guarente; P A Sharp
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

7.  Factors involved in specific transcription by mammalian RNA polymerase II: role of transcription factors IIA, IID, and IIB during formation of a transcription-competent complex.

Authors:  E Maldonado; I Ha; P Cortes; L Weis; D Reinberg
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

8.  RNA polymerase II C-terminal repeat influences response to transcriptional enhancer signals.

Authors:  C Scafe; D Chao; J Lopes; J P Hirsch; S Henry; R A Young
Journal:  Nature       Date:  1990-10-04       Impact factor: 49.962

9.  Prokaryotic and eukaryotic RNA polymerases have homologous core subunits.

Authors:  D Sweetser; M Nonet; R A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

10.  Two dissociable subunits of yeast RNA polymerase II stimulate the initiation of transcription at a promoter in vitro.

Authors:  A M Edwards; C M Kane; R A Young; R D Kornberg
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

View more
  17 in total

1.  BRCA1 at a branch point.

Authors:  J D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

2.  Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.

Authors:  L J Huber; T W Yang; C J Sarkisian; S R Master; C X Deng; L A Chodosh
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase.

Authors:  Andrew A Horwitz; El Bachir Affar; George F Heine; Yang Shi; Jeffrey D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

4.  Multiple mechanisms contribute to inhibit transcription in response to DNA damage.

Authors:  George F Heine; Andrew A Horwitz; Jeffrey D Parvin
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

5.  Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

Authors:  J Vallon-Christersson; C Cayanan; K Haraldsson; N Loman; J T Bergthorsson; K Brøndum-Nielsen; A M Gerdes; P Møller; U Kristoffersson; H Olsson; A Borg; A N Monteiro
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

6.  Predicting physical interactions between protein complexes.

Authors:  Trevor Clancy; Einar Andreas Rødland; Ståle Nygard; Eivind Hovig
Journal:  Mol Cell Proteomics       Date:  2013-02-25       Impact factor: 5.911

7.  Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays.

Authors:  S Lafarge; M-H Montané
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

Review 8.  MYC in breast tumor progression.

Authors:  Yinghua Chen; Olufunmilayo I Olopade
Journal:  Expert Rev Anticancer Ther       Date:  2008-10       Impact factor: 4.512

9.  BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines.

Authors:  Natalie Tulchin; Monique Chambon; Gloria Juan; Steven Dikman; James Strauchen; Leonard Ornstein; Blase Billack; Nicholas T Woods; Alvaro N A Monteiro
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

10.  Subcellular localization of RPB5-mediating protein and its putative functional partner.

Authors:  Luvsanjav Delgermaa; Naoyuki Hayashi; Dorjbal Dorjsuren; Takahiro Nomura; Le Thi-Thu Thuy; Seishi Murakami
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.